Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-07-02

Clinical Trial Update: The Use of Tadalafil in Confirmed COVID-19 Pneumonia. [Phase 4]

View source ↗

Summary

Phase 4 trial exploring tadalafil for confirmed COVID-19 pneumonia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Santa Barbara Cottage Hospital | Conditions: COVID, Sars-CoV2 | Phase 4 | Status: WITHDRAWN